Discover undervalued stocks with Eulerpool.

KORU Medical Systems Stock KRMD

Price

0
Today +/-
-0
Today %
-0 %

KORU Medical Systems stock price

Loading chart...
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the KORU Medical Systems stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the KORU Medical Systems stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the KORU Medical Systems stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze KORU Medical Systems's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

KORU Medical Systems Stock Price History

DateKORU Medical Systems Price
10/17/20250 undefined
10/17/20254.06 undefined
10/16/20254.03 undefined
10/15/20254.08 undefined
10/14/20254.15 undefined
10/13/20254.08 undefined
10/10/20254.25 undefined
10/9/20254.28 undefined
10/8/20254.21 undefined
10/7/20253.94 undefined
10/6/20253.97 undefined
10/3/20253.85 undefined
10/2/20253.79 undefined
10/1/20253.82 undefined
9/30/20253.84 undefined
9/28/20253.84 undefined
9/25/20253.96 undefined
9/24/20253.92 undefined
9/24/20253.96 undefined
9/23/20254.03 undefined
9/22/20254.03 undefined

KORU Medical Systems Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into KORU Medical Systems, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by KORU Medical Systems from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects KORU Medical Systems’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of KORU Medical Systems. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into KORU Medical Systems’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing KORU Medical Systems’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on KORU Medical Systems’s growth potential.

KORU Medical Systems Revenue, EBIT and net profit per share

DateKORU Medical Systems RevenueKORU Medical Systems EBITKORU Medical Systems Net Income
2027e54.06 M undefined1.03 M undefined934,375.1 undefined
2026e47.41 M undefined-1.41 M undefined-1.12 M undefined
2025e40.74 M undefined-4.26 M undefined-3.74 M undefined
202433.65 M undefined-6.45 M undefined-6.07 M undefined
202328.52 M undefined-10.27 M undefined-13.74 M undefined
202227.9 M undefined-10.78 M undefined-8.66 M undefined
202123.49 M undefined-7.03 M undefined-4.56 M undefined
202024.18 M undefined1.2 M undefined-1.21 M undefined
201923.16 M undefined4.01 M undefined560,000 undefined
201817.35 M undefined1.16 M undefined910,000 undefined
201713.31 M undefined1.24 M undefined900,000 undefined
201612.29 M undefined-740,000 undefined-540,000 undefined
201512.25 M undefined1.18 M undefined780,000 undefined
201411.24 M undefined1.15 M undefined750,000 undefined
20138.7 M undefined1.01 M undefined700,000 undefined
20127.76 M undefined1.06 M undefined730,000 undefined
20116.39 M undefined1.29 M undefined820,000 undefined
20104.92 M undefined1.19 M undefined700,000 undefined
20093.77 M undefined720,000 undefined880,000 undefined
20083.44 M undefined780,000 undefined1.02 M undefined
20072.35 M undefined190,000 undefined-10,000 undefined
20061.74 M undefined-20,000 undefined-260,000 undefined
20051.75 M undefined-180,000 undefined-230,000 undefined

KORU Medical Systems Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (k)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
0000011232212211111123346781112121317232423272833404754
-------100.0050.00-33.33--50.00100.00--50.00-----100.0050.00-33.3350.0016.6714.2937.509.09-8.3330.7735.294.35-4.1717.393.7017.8621.2117.5014.89
-----2,100.002,100.0050.0033.3350.0050.002,100.001,050.001,050.002,100.002,100.002,100.002,100.00100.00100.0050.0066.6766.6775.0066.6757.1462.5054.5558.3358.3361.5458.8260.8758.3356.5255.5657.1463.6452.5044.6838.89
000000011110000000111223445677810141413151621000
00000001,000000-1,0000000000001,00000000000000-1,000-4,000-8,000-13,000-6,000-3,000-1,0000
----------------------------------300.00100.0062.50-53.85-50.00-66.67-
20.0220.0320.0320.0320.3321.9121.9622.4625.5225.5822.1422.1423.1223.3523.523.523.5422.726.4729.8732.6834.8335.3836.2435.136.0436.6637.6337.9937.8338.4538.9239.0641.9344.394545.645.8000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

Revenue and Growth

The KORU Medical Systems Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the KORU Medical Systems is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (k)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (k)
GOODWILL (k)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (k)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (k)
SHORT-TERM DEBTS (k)
LONG-TERM DEBT PORTION (k)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (k)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
19891990199119921993199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                     
0.0900.020.130.221.130.730.790.760.170.040.030.020.220.040.030.10.10.520.811.472.012.192.492.824.463.584.245.265.8727.3225.3317.4111.489.58
0.10.090.080.120.180.090.150.230.120.230.210.20.180.130.130.150.210.30.490.650.710.881.111.741.621.351.671.861.433.232.573.593.564.055.72
000000000000000000000000000000072097028.9277.2
0.30.360.340.320.320.540.520.640.570.560.590.60.380.380.370.350.490.550.620.630.671.171.150.821.231.041.351.662.12.396.836.116.43.482.8
0.020.020.020.030.020.230.240.230.270.050.090.010.010.030.040.030.010.040.380.380.160.190.180.250.240.270.180.170.250.390.811.571.461.220.75
0.510.470.460.60.741.991.641.891.721.010.930.840.590.760.580.560.810.992.012.473.014.254.635.35.917.126.787.939.0411.8837.5337.3229.820.2619.13
0.240.140.160.150.190.321.621.720.520.480.470.470.420.360.340.270.220.240.230.220.360.50.880.841.1610.930.840.860.991.41.27.677.357.26
00000000000000000000000000000000000
00000000000000000000000000000000000
000000303030404040404040404040403030202040180250430480630810840810790754.4730.3
000000101010101010101010101010100000000000000000
0.170.140.120.090.080.180.050.390.020.0400.050.060.030.030.060.060.030.030.250.030.030.060.030.030.030.030.030.020.210.151.964.070.10.1
0.410.280.280.240.270.51.712.150.580.570.520.570.530.440.420.380.330.320.310.50.420.550.960.911.371.281.391.351.512.012.393.9712.538.218.09
0.920.750.740.841.012.493.354.042.31.581.451.411.121.210.941.141.312.322.973.434.85.596.217.288.48.179.2810.5513.8939.9241.2942.3328.4627.22
                                                                     
200200200220220220220220220230190240240250260290310350350360370370210340350380410410410420470480490490.9493.8
2.872.872.882.933.043.033.043.043.042.032.212.212.212.252.32.452.612.852.913.013.023.263.513.513.863.974.134.224.66.2935.8840.7744.2547.0249.58
-2.58-2.79-2.92-2.9-2.76-1.09-0.95-1.25-2.58-1.46-1.57-1.97-2.24-2.53-2.94-3.16-3.43-3.44-2.42-1.53-0.760.050.781.482.243.022.483.394.34.863.65-0.91-9.57-23.31-29.38
00000000000000000000000000000000000
00000000000000000000000000000000000
0.490.280.160.250.52.162.312.010.680.80.830.480.21-0.03-0.38-0.42-0.51-0.240.841.842.633.684.55.336.457.377.028.029.3111.574040.3435.1724.220.7
0.050.060.120.070.070.110.120.140.040.060.10.190.270.330.350.310.440.340.220.080.160.20.110.250.240.310.770.450.450.570.621.232.390.981.65
0000000.060.120.080.190.130.150.070.10.150.140.140.190.260.250.090.290.350.50.430.780.591.111.131.833.042.973.782.545.14
40202013012090010027027030200000209012090202020202020202000090260512.529.3
1016018040400036044007027020020020020004000000000000000510430314.3271.2
00000020906001020303030207020120704040500000001000100109.5115.6
0.10.240.320.240.230.20.20.810.890.520.340.650.570.660.730.670.671.040.720.490.310.550.530.770.691.111.381.581.582.413.664.86.964.457.2
0.02000.110.0700.871.080.1900.030.060.130.380.460.530.860.430.680.620.480.440.390000000000.390.320.2
00000000000000000000012020016025012080200000000
000000000.430.410.380.360.360.340.320.290.250.230.20.180.160.130.110.090.070.040.02000.240.103.653.343
0.02000.110.0700.871.080.620.410.410.420.490.720.780.821.110.660.880.80.640.690.70.250.320.160.10.0200.240.104.043.653.2
0.120.240.320.350.30.21.071.891.510.930.751.071.061.381.511.491.781.71.61.290.951.241.231.021.011.271.481.61.582.653.764.8118.1110.4
0.610.520.480.60.82.363.383.92.191.731.581.551.271.351.131.071.271.462.443.133.584.925.736.357.468.648.59.6210.8914.2243.7645.1446.1732.331.1
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of KORU Medical Systems provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand KORU Medical Systems's financial health and stability.

Assets

KORU Medical Systems's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that KORU Medical Systems must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of KORU Medical Systems after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into KORU Medical Systems's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (k)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (k)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (k)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (k)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
198919901991199219931994null19951996null19971998null19992000null20012002null20032004null20052006null20072008null20092010null20112012null20132014null20152016nullnull201720182019202020212022
000001,0001,0000000-1,000-1,00000000000000001,00000000000000000000-1,000-4,000-8,000
00000000000000000000000000000000000000000000000
000000000000000000000000000000000000000000000-1-2
0000000000000000000000000000000000000000000-1,000-2,000-1,0001,000
00000000000000000000000000000000000000000002456
00000000000000000000000000000000000000000000000
00000000000000000000000000000000000000000000000
000000000000000000000000000001,0001,0000000001,00001,000001,00000-4,000-5,000
00000000-100000000000000000000000000000000000-10-2
00000000-1,000001,0001,00000000000000000000000000000000-1,0001,000-1,0000-2,000
000000000001,0001,00000000000000000000000000000000-1,0001,000000
00000000000000000000000000000000000000000000000
00000000000000000000000000000000000000000000000
000000000000000000000000000000000000000000002320
00000000000-1-100000000000000000000000000000002320
-----------------------------------------------
00000000000000000000000000000000000000000000000
0000000000000000000000000000000000000101000221-1-7
-0.44-0.31-0.010.090.010.5600.11-0.840-0.56-0.1600.06-0.210-0.24-0.010-0.06-0.250-0.15-0.1100.070.4700.320.8300.320.2100.730.0901.71-0.75000.681-0.11-1.8-4.7-8.2
00000000000000000000000000000000000000000000000

KORU Medical Systems stock margins

The KORU Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of KORU Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for KORU Medical Systems.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the KORU Medical Systems's sales revenue. A higher gross margin percentage indicates that the KORU Medical Systems retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the KORU Medical Systems's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the KORU Medical Systems's total revenue generated. When comparing the revenue margin year over year, investors can gauge the KORU Medical Systems's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the KORU Medical Systems. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the KORU Medical Systems's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

KORU Medical Systems Margin History

KORU Medical Systems Gross marginKORU Medical Systems Profit marginKORU Medical Systems EBIT marginKORU Medical Systems Profit margin
2027e63.4 %1.91 %1.73 %
2026e63.4 %-2.98 %-2.37 %
2025e63.4 %-10.45 %-9.17 %
202463.4 %-19.16 %-18.03 %
202358.59 %-36.01 %-48.18 %
202255.09 %-38.64 %-31.04 %
202158.62 %-29.93 %-19.41 %
202061.79 %4.96 %-5 %
201964.12 %17.31 %2.42 %
201862.31 %6.69 %5.24 %
201761.16 %9.32 %6.76 %
201661.59 %-6.02 %-4.39 %
201562.04 %9.63 %6.37 %
201459.52 %10.23 %6.67 %
201361.03 %11.61 %8.05 %
201263.66 %13.66 %9.41 %
201164.79 %20.19 %12.83 %
201066.26 %24.19 %14.23 %
200966.58 %19.1 %23.34 %
200863.95 %22.67 %29.65 %
200761.7 %8.09 %-0.43 %
200661.49 %-1.15 %-14.94 %
200558.29 %-10.29 %-13.14 %

KORU Medical Systems Stock Sales Revenue, EBIT, Earnings per Share

The KORU Medical Systems earnings per share therefore indicates how much revenue KORU Medical Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue KORU Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates KORU Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of KORU Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating KORU Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

KORU Medical Systems Revenue, EBIT and net profit per share

DateKORU Medical Systems Sales per ShareKORU Medical Systems EBIT per shareKORU Medical Systems Earnings per Share
2027e1.18 undefined0.02 undefined0.02 undefined
2026e1.04 undefined-0.03 undefined-0.02 undefined
2025e0.89 undefined-0.09 undefined-0.08 undefined
20240.73 undefined-0.14 undefined-0.13 undefined
20230.63 undefined-0.23 undefined-0.3 undefined
20220.62 undefined-0.24 undefined-0.19 undefined
20210.53 undefined-0.16 undefined-0.1 undefined
20200.58 undefined0.03 undefined-0.03 undefined
20190.59 undefined0.1 undefined0.01 undefined
20180.45 undefined0.03 undefined0.02 undefined
20170.35 undefined0.03 undefined0.02 undefined
20160.32 undefined-0.02 undefined-0.01 undefined
20150.32 undefined0.03 undefined0.02 undefined
20140.3 undefined0.03 undefined0.02 undefined
20130.24 undefined0.03 undefined0.02 undefined
20120.22 undefined0.03 undefined0.02 undefined
20110.18 undefined0.04 undefined0.02 undefined
20100.14 undefined0.03 undefined0.02 undefined
20090.11 undefined0.02 undefined0.02 undefined
20080.1 undefined0.02 undefined0.03 undefined
20070.07 undefined0.01 undefined-0 undefined
20060.06 undefined-0 undefined-0.01 undefined
20050.07 undefined-0.01 undefined-0.01 undefined

KORU Medical Systems business model

Repro Med Systems Inc is a US-based company specializing in the development and manufacturing of medical devices for infusion therapy. The company was founded in 1980 by Edward L. Swanson and is headquartered in Chester, New York. Repro Med Systems Inc started as a small family business developing medical devices for reproductive medicine. Over the years, the company expanded and began focusing on other medical applications. In the 1990s, the company developed an innovative infusion pump system, later known as the "Freedom Syringe Infusion System." This system received numerous patents and proved to be a groundbreaking innovation in infusion therapy. Repro Med Systems Inc specializes in selling medical devices for infusion therapy. The company uses a direct sales model, allowing them to sell products directly to end customers. This enables the company to better understand customer needs and quickly respond to industry changes. Repro Med Systems Inc offers a variety of products for infusion therapy, including the "Freedom Syringe Infusion System," the "MRidium" infusion pump system, and the "Freo" intermittent dosing infusion pump system. The "Freedom Syringe Infusion System" is a portable infusion pump system that allows the administration of medications and fluids through a needleless disposable syringe. The system is easier to use than conventional infusion pumps and provides patients with more freedom and mobility during treatment. The "MRidium" infusion pump system has been specifically designed for use in magnetic resonance imaging (MRI). The system is immune to magnetic interference and can be used during an MRI examination to provide patients with infusions. The "Freo" intermittent dosing infusion pump system is a simple and reliable system that allows the administration of medications in variable doses. The system is ideal for pain management and enables patients to administer their medications quickly and easily. In conclusion, Repro Med Systems Inc is an innovative company specializing in the development and manufacturing of medical devices for infusion therapy. The company has experienced remarkable growth in recent years and is now a key player in the industry. With its focus on innovation and customer satisfaction, the company is expected to continue to be successful in the future. KORU Medical Systems is one of the most popular companies on Eulerpool.com.

KORU Medical Systems SWOT Analysis

Strengths

Repro Med Systems Inc (RMS) benefits from several strengths that contribute to its success in the market. One of its key strengths is its proprietary product portfolio, which includes the innovative Freedom infusion system. This product offers unique advantages such as portability, disposability, and ease of use, giving RMS a competitive edge.

Another strength of RMS is its strong market presence and established customer base. The company has built solid relationships with healthcare providers and distributors, which helps in generating recurring revenue and ensures a steady stream of sales.

Weaknesses

Despite its strengths, RMS also faces certain weaknesses that need to be addressed. One weakness is its dependency on a limited number of key suppliers for critical components of its products. Any disruptions in the supply chain can have a significant impact on production and delivery timelines.

Additionally, RMS has a relatively small product portfolio compared to some of its competitors. This narrow product range limits the company's ability to cater to diverse customer needs and potentially hinders its market expansion efforts.

Opportunities

The healthcare industry is experiencing significant growth, presenting ample opportunities for RMS. The increasing prevalence of chronic diseases and the rising elderly population create a higher demand for home-based medical devices, such as RMS' infusion systems. By capitalizing on this trend, RMS can expand its customer base and increase its market share.

Another opportunity for RMS lies in the emerging markets, where the demand for medical devices is steadily growing. By strategically targeting these markets and adapting its products to meet local requirements, RMS can tap into new revenue streams and achieve global expansion.

Threats

RMS faces several threats that could potentially impact its business. One major threat is intense competition from other medical device manufacturers. The healthcare industry is highly competitive, and RMS needs to continuously innovate and differentiate its products to stay ahead of rivals.

Additionally, regulatory challenges pose a threat to RMS's operations. Compliance with strict regulations and obtaining necessary approvals can be time-consuming and costly. Any delays in obtaining regulatory approvals can hinder product launches and impede market growth.

KORU Medical Systems Revenue by Region

  • 3 years

  • Max

Details
Details

Revenue by Segment

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

KORU Medical Systems Revenue by Segment

DateDomesticInternationalOther CountriesUnited States
2023--4.84 M USD23.68 M USD
2022--4.31 M USD23.59 M USD
2021--4 M USD19.49 M USD
202020.68 M USD3.5 M USD--
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

KORU Medical Systems Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

KORU Medical Systems historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

KORU Medical Systems shares outstanding

The number of shares was KORU Medical Systems in 2024 — This indicates how many shares 45.803 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue KORU Medical Systems earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates KORU Medical Systems's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of KORU Medical Systems’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating KORU Medical Systems's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for KORU Medical Systems.

KORU Medical Systems latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.02 (100 %)2025 Q2
3/31/2025-0.03 -0.02  (24.53 %)2025 Q1
12/31/2024-0.03 -0.03  (3.85 %)2024 Q4
9/30/2024-0.04 -0.03  (22.68 %)2024 Q3
6/30/2024-0.04 -0.02  (53.27 %)2024 Q2
3/31/2024-0.04 -0.02  (48.45 %)2024 Q1
12/31/2023-0.04 -0.03  (26.47 %)2023 Q4
9/30/2023-0.05 -0.03  (41.18 %)2023 Q3
6/30/2023-0.06 -0.05  (13.49 %)2023 Q2
3/31/2023-0.05 -0.05  (1.96 %)2023 Q1
1
2

Eulerpool ESG Scorecard© for the KORU Medical Systems stock

Eulerpool World ESG Rating (EESG©)

35/ 100

🌱 Environment

32

👫 Social

19

🏛️ Governance

53

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees51
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

KORU Medical Systems shareholders

%
Name
Stocks
Change
Date
21.34211 % Horton Capital Management LLC9,775,261-876,7582/24/2023
13.83779 % First Light Asset Management, LLC6,338,08264,30912/31/2022
6.48375 % Archon Capital Management LLC2,969,732012/31/2022
3.78829 % Frommer (Kathy S)1,735,1395,2213/31/2022
2.93996 % The Vanguard Group, Inc.1,346,58267812/31/2022
1.97374 % B. Riley Asset Management, LLC904,025130,10012/31/2022
1.91354 % Albion Financial Group876,452-55,54812/31/2022
1.86670 % Altium Capital Management LP855,000-140,50012/31/2022
1.68747 % Fisher (Karen)772,906100,0003/1/2022
1.57863 % Parkman Healthcare Partners LLC723,05639,59012/31/2022
1
2
3
4
5
...
10

KORU Medical Systems Executives and Management Board

Ms. Linda Tharby

(53)
KORU Medical Systems President, Chief Executive Officer
Compensation 725,169

Mr. James Beck

(74)
KORU Medical Systems Independent Director (since 2018)
Compensation 397,714

Ms. Karen Fisher

(56)
KORU Medical Systems Chief Financial Officer, Secretary, Treasurer
Compensation 297,994

Mr. Manuel Marques

(49)
KORU Medical Systems Chief Operating Officer
Compensation 260,249

Mr. R. John Fletcher

(76)
KORU Medical Systems Independent Chairman of the Board
Compensation 102,335
1
2

KORU Medical Systems Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer-0,68-0,210,630,600,66-0,19
1

Most common questions regarding KORU Medical Systems

What values and corporate philosophy does KORU Medical Systems represent?

Repro Med Systems Inc, a leading stock in the healthcare sector, represents core values of innovation, excellence, and dedication to patient care. With their robust corporate philosophy, Repro Med Systems Inc strives to provide cutting-edge medical devices and solutions that enhance the quality of life for patients. The company's mission revolves around delivering safe, reliable, and efficient medical technologies, ensuring positive medical outcomes and improving patient experiences. Repro Med Systems Inc's commitment to customer satisfaction, continuous improvement, and ethical business practices truly sets them apart in the industry. By embracing these values, Repro Med Systems Inc establishes itself as a trusted and valued healthcare provider.

In which countries and regions is KORU Medical Systems primarily present?

Repro Med Systems Inc, also known as RMS Medical Products, is primarily present in various countries and regions worldwide. The company operates globally, with a significant presence in North America, including the United States and Canada. Additionally, Repro Med Systems Inc has extended its reach to several international markets, such as Europe, particularly in the United Kingdom, Germany, France, Italy, and Spain. Moreover, the company has established a strong presence in the Asia-Pacific region, including Japan, China, and Australia. With its global presence, Repro Med Systems Inc serves a diverse customer base across different continents.

What significant milestones has the company KORU Medical Systems achieved?

Repro Med Systems Inc, a renowned medical device company, has achieved significant milestones throughout its existence. Over the years, the company has successfully developed and marketed innovative medical products, firmly establishing itself as a leader in the industry. Repro Med Systems Inc has gained recognition for its proprietary technology, particularly its market-leading primary product, the FREEDOM60® and FreedomEdge™ Syringe Infusion Systems. These devices have revolutionized the way patients receive medication, offering enhanced convenience, safety, and precision. With a strong commitment to research and development, Repro Med Systems Inc has continually expanded its product portfolio, meeting the evolving needs of healthcare providers and patients alike.

What is the history and background of the company KORU Medical Systems?

Repro Med Systems Inc, commonly known as RMS Medical Products, is a leading medical device company specializing in the development and commercialization of advanced infusion solutions. With a rich history spanning over 30 years, RMS has established itself as a trusted provider of innovative medical products that improve patient outcomes. The company's flagship product, the FREEDOM Syringe Infusion System, revolutionizes the way medication is delivered, offering patients a convenient and effective alternative to traditional infusion methods. As a pioneer in the industry, Repro Med Systems Inc continues to invest in research and development, ensuring its products remain at the forefront of medical advancements.

Who are the main competitors of KORU Medical Systems in the market?

The main competitors of Repro Med Systems Inc in the market include other medical device companies such as Becton, Dickinson and Company (BD), Baxter International Inc., and Teleflex Incorporated. These companies also offer a range of medical devices and solutions, competing with Repro Med Systems Inc in the same market segment.

In which industries is KORU Medical Systems primarily active?

Repro Med Systems Inc, also known as RMS Medical Products, primarily operates in the medical devices industry. With a focus on innovative medical solutions, RMS specializes in the development, manufacture, and distribution of portable and easy-to-use medical devices. These devices primarily assist with the administration of fluids and medications in various healthcare settings. The company's products, like the Freedom Syringe Infusion System, are designed to enhance patients' quality of life by providing effective and convenient treatment options. As a leader in this industry, Repro Med Systems Inc continues to provide cutting-edge solutions that positively impact healthcare delivery.

What is the business model of KORU Medical Systems?

The business model of Repro Med Systems Inc is focused on the development, manufacturing, and marketing of innovative medical devices. The company specializes in the design of proprietary infusion technologies, primarily catering to patients with chronic diseases and conditions. Repro Med Systems Inc aims to provide superior and convenient solutions for patients requiring infusion therapy, resulting in improved quality of life and enhanced healthcare outcomes. With their expertise in the field, the company continually strives to meet the evolving needs of patients and healthcare professionals alike, positioning itself as a leader in the medical device industry.

What is the P/E ratio of KORU Medical Systems 2025?

The P/E ratio cannot be calculated for KORU Medical Systems at the moment.

What is the P/S ratio of KORU Medical Systems 2025?

The P/S cannot be calculated for KORU Medical Systems currently.

What is the Quality Investing of KORU Medical Systems?

The Quality Investing for KORU Medical Systems is 4/10.

What is the revenue of KORU Medical Systems 2025?

The expected KORU Medical Systems revenue is 40.74 M USD.

How high is the profit of KORU Medical Systems 2025?

The expected KORU Medical Systems profit is -3.74 M USD.

What is the business model of KORU Medical Systems

Repro Med Systems Inc (RMS) is a leading provider of medical devices and consumables for infusion and pain therapy. The company was founded in 1980 and is headquartered in Chester, New York. RMS's business model focuses on three main areas: infusion pumps, pain therapy systems, and consumables. One of RMS's key product lines is infusion pumps. The company offers a wide range of portable and stationary infusion pumps used in the administration of fluids and medications to patients. These devices enable accurate dosing and monitoring of infusions, contributing to the safety and effectiveness of treatment. Another important area for RMS is pain therapy. The company offers systems for controlled pain delivery, allowing effective pain relief for patients with acute or chronic pain. RMS provides both portable and stationary pain therapy systems that enable accurate dosing and individual adjustment of pain medications. Consumables such as catheters, syringes, and tubes are also an important part of RMS's offering. The company provides high-quality and reliable products specifically designed for use with their infusion pumps and pain therapy systems. RMS focuses on developing and marketing innovative medical devices and consumables that contribute to the quality and efficiency of patient care. The company works closely with physicians, nurses, and other healthcare providers to understand patient needs and provide the best possible solutions. The company sells its products in the US and worldwide through a network of dealers, distributors, and online platforms. RMS has a strong presence in North America but also operates in Europe, Asia, and other regions. The company places great value on customer satisfaction and offers comprehensive customer support and training. Overall, RMS is an established and successful provider of medical devices and consumables for infusion and pain therapy. The company benefits from a strong market position, innovative products, and an experienced management team. With its broad product line and strong distribution network, RMS is well positioned to continue growing and expanding in the future.

What is the KORU Medical Systems dividend?

KORU Medical Systems pays a dividend of 0 USD distributed over payouts per year.

How often does KORU Medical Systems pay dividends?

The dividend cannot currently be calculated for KORU Medical Systems or the company does not pay out a dividend.

What is the KORU Medical Systems ISIN?

The ISIN of KORU Medical Systems is US7599101026.

What is the KORU Medical Systems WKN?

The WKN of KORU Medical Systems is 913004.

What is the KORU Medical Systems ticker?

The ticker of KORU Medical Systems is KRMD.

How much dividend does KORU Medical Systems pay?

Over the past 12 months, KORU Medical Systems paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, KORU Medical Systems is expected to pay a dividend of 0 USD.

What is the dividend yield of KORU Medical Systems?

The current dividend yield of KORU Medical Systems is .

When does KORU Medical Systems pay dividends?

KORU Medical Systems pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of KORU Medical Systems?

KORU Medical Systems paid dividends every year for the past 0 years.

What is the dividend of KORU Medical Systems?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is KORU Medical Systems located?

KORU Medical Systems is assigned to the 'Health' sector.

Wann musste ich die Aktien von KORU Medical Systems kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of KORU Medical Systems from 10/20/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/20/2025.

When did KORU Medical Systems pay the last dividend?

The last dividend was paid out on 10/20/2025.

What was the dividend of KORU Medical Systems in the year 2024?

In the year 2024, KORU Medical Systems distributed 0 USD as dividends.

In which currency does KORU Medical Systems pay out the dividend?

The dividends of KORU Medical Systems are distributed in USD.

All fundamentals about KORU Medical Systems

Our stock analysis for KORU Medical Systems Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KORU Medical Systems Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.